Summit Rock Advisors, LP Diversified Active

Location: New York, NY

CIK: 0001540951 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 10, 2020

Total Value: $107M (100.0% shares, 0.0% debt)

Holdings (5)

ACWI ISHARES TR 65.8%

Value $70.6M Shares 957,719 Est. Cost $72.06 Unrealized —

HYG ISHARES TR 13.8%

Value $14.77M Shares 180,999 Est. Cost $81.62 Unrealized —

VOO VANGUARD INDEX FDS 10.4%

Value $11.21M Shares 39,558 Est. Cost $283.43 Unrealized —

ICVT ISHARES TR 9.0%

Value $9.61M Shares 135,431 Est. Cost $70.96 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 1.1%

Value $1.144M Shares 34,776 Est. Cost $38.42 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACWI	ISHARES TR	957,719	$70.6M	65.8%	$72.06	—	MSCI ACWI ETF	464288257
HYG	ISHARES TR	180,999	$14.77M	13.8%	$81.62	—	IBOXX HI YD ETF	464288513
VOO	VANGUARD INDEX FDS	39,558	$11.21M	10.4%	$283.43	—	S&P 500 ETF SHS	922908363
ICVT	ISHARES TR	135,431	$9.61M	9.0%	$70.96	—	CONV BD ETF	46435G102
PHAT	PHATHOM PHARMACEUTICALS INC	34,776	$1.144M	1.1%	$38.42	0.0%	COM	71722W107